Answer
Frovatriptan (Migard) activates 5-HT1B/1D receptors and is believed to relieve migraine by selectively inhibiting excessive widening of intracranial arteries outside the brain.
Sources for this answer
- MigardA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §5.1 Pharmacodynamic properties · Version 11Document updated
Sources checked